Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gastrointestinal epithelial cells are the highly specialized and dynamic cell populations lining the gastrointestinal tract. They form a single-cell-thick barrier that mediates nutrient absorption, secretion, and immune interactions, and maintain a critical interface between the lumen and the underlying tissue. Major classes include enterocytes (absorption), goblet cells (mucus secretion), Paneth cells (antimicrobial defense), and enteroendocrine cells (hormone secretion). These populations are continuously replenished from stem cells in the crypts and undergo rapid turnover. Disruption of gastrointestinal epithelial cell functions is central to many diseases, including inflammatory, infectious, and neoplastic conditions
Not applicable as a collective; mechanisms are specific to drugs acting on subpopulations or pathways (e.g., anti-inflammatory action on enterocytes, modulating mucus production in goblet cells, stimulating hormone release from enteroendocrine cells)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gastrointestinal epithelial cell (null).